Correlation Between Rigolleau and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rigolleau and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigolleau and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigolleau SA and Pfizer Inc, you can compare the effects of market volatilities on Rigolleau and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigolleau with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigolleau and Pfizer.

Diversification Opportunities for Rigolleau and Pfizer

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Rigolleau and Pfizer is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Rigolleau SA and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Rigolleau is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigolleau SA are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Rigolleau i.e., Rigolleau and Pfizer go up and down completely randomly.

Pair Corralation between Rigolleau and Pfizer

Assuming the 90 days trading horizon Rigolleau SA is expected to under-perform the Pfizer. In addition to that, Rigolleau is 2.84 times more volatile than Pfizer Inc. It trades about -0.03 of its total potential returns per unit of risk. Pfizer Inc is currently generating about 0.18 per unit of volatility. If you would invest  650,000  in Pfizer Inc on April 22, 2025 and sell it today you would earn a total of  142,000  from holding Pfizer Inc or generate 21.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Rigolleau SA  vs.  Pfizer Inc

 Performance 
       Timeline  
Rigolleau SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Rigolleau SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Pfizer Inc 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Pfizer sustained solid returns over the last few months and may actually be approaching a breakup point.

Rigolleau and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rigolleau and Pfizer

The main advantage of trading using opposite Rigolleau and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigolleau position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Rigolleau SA and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk